| HOME >> BIOLOGY >> TECHNOLOGY |
SAN ANTONIO, Dec. 6, 2011 /PRNewswire/ -- For 65 years, Mission Pharmacal Company has remained true to the commitment of its founder H.N. Walsdorf to provide the highest quality healthcare medications and treatments available to consumers. Even as the global economy continues to be uncertain, this Texas-based company remains steadfast in its loyalty to employees and consumers as it continues to search for more and better prescription and consumer products to add to its four expanding therapeutic areas of focus: women's health, urology, pediatrics, and dermatology. This passion and fierce determination to provide treatments and therapies for a wide range of conditions and diseases have helped Mission Pharmacal grow to be a recognized leader in the pharmaceutical industry.
Owned by the Walsdorf family, Mission proudly retains the founder's commitment to quality and innovation. More than six decades of steady growth and consistent profitability have not shifted Mission's focus that starts with the selection of superior raw materials, continues through state-of-the-art manufacturing facilities, and finishes with product packaging that reflects the company's emphasis on patient well-being.
As a family-owned and family-run business, Mission Pharmacal truly recognizes the importance of meeting the market needs of families. "When a mother is buying healthcare products for her family, we want her to look for the Mission Pharmacal label," says Neill Walsdorf Jr., president of Mission Pharmacal. "And when she sees that label, we want her to know that she is holding a product of unquestioned effectiveness and unmatched quality. We intend to keep pace with market needs, wherever that may lead us. This is our commitment."
Mission Pharmacal extends this commitment to families and the community by partnering with other manufacturers and organizations to support community health programs and fund-raising effor
'/>"/>
| SOURCE Mission Pharmacal Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. Regenicin to Present at Event Celebrating Advancements in Regenerative Medicine
2. MedNet Solutions Achieves the Inc. 5000 List Five Years in a Row
3. Thirty Years After 1st American "Test-Tube Baby," Economy May Be Biggest Obstacle for Infertile Couples
4. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
5. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
6. CAS Chemistry Research Report: 40 Years of Biofuel Research Reveal China Now Atop U.S. in Patenting and Commercialization of Bioethanol
7. $1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years
8. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
9. Lancaster Laboratories -- First Lab to be A2LA Accredited for 30 Consecutive Years
10. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
11. 40 Years on the Leading Edge: Case Western Reserve Universitys Biomedical Engineering Department Commemorates Achievement, Looks to Future
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |